LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Industry	912.36M	978.12M	1.16B	1.01B	798.52M
Food Industry	3.17M	2.11M	1.80M	1.66M	11.94M
Testing Industry	-	-	94.23K	30.83M	-
Consumer Goods Industry	-	-	-	744.26K	7.17M
Total	915.53M	980.23M	1.16B	1.04B	817.64M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	804.88M	873.83M	1.06B	964.91M	761.28M
Foreign	110.65M	106.39M	103.78M	77.48M	56.36M
Total	915.53M	980.23M	1.16B	1.04B	817.64M

Data Source: S&P Global Market Intelligence Last updated: Aug 19, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error